LAURA D. MILLMAN, Special Master.
On May 22, 2017, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. §§ 300aa-10-34 (2012), alleging that influenza ("flu") vaccine administered on September 23, 2015 caused her Guillain-Barré syndrome ("GBS") and chronic inflammatory demyelinating polyneuropathy ("CIDP"). Pet. at ¶¶ 5 and 9. On January 19, 2018, the undersigned dismissed the case. On June 29, 2018, petitioner filed a motion for attorneys' fees and costs. For the reasons set forth below, the undersigned
Petitioner filed her petition on May 22, 2017. The case was assigned to the undersigned on May 23, 2017.
Petitioner filed medical records and an affidavit. On July 17, 2017, petitioner filed a statement of completion of the record.
In her Order of August 11, 2017, the undersigned raised her concern about whether, in light of the medical records and opinions of the treating doctors, it was reasonable for petitioner to proceed. Doc 13. The undersigned listed numerous issues including that the onset of GBS was over 5 months after vaccination,
During the initial status conference held on August 22, 2017, the undersigned discussed the Order of August 11, 2017 with the parties. Petitioner's counsel discussed the possibility of amending her petition to allege significant aggravation of a preexisting neurological injury and requested time to consider how to proceed.
During a status conference held on October 5, 2017, petitioner's counsel requested 30 days to get in touch with petitioner's treating neurologist, Dr. Oakley Bailey, who diagnosed her with GBS on February 24, 2016. The undersigned suggested that petitioner's counsel send Dr. Bailey the Order of August 11, 2017 with petitioner's full medical records.
On November 17, 2017, the undersigned gave petitioner until December 18, 2017 to either move to dismiss the petition or file a status report.
On December 18, 2017, petitioner's counsel filed a status report which was an informal motion for an extension of time to determine whether Dr. Bailey was willing to support petitioner's allegations. On December 19, 2017, the undersigned gave petitioner until January 17, 2018 to file either Dr. Bailey's report and records or a motion to dismiss the case.
On January 17, 2018, petitioner moved to dismiss the petition stating she was unable to prove her case.
On January 19, 2018, the undersigned dismissed the case. Judgment entered on February 22, 2018.
On June 29, 2018, petitioner filed a motion for attorneys' fees and costs. Petitioner requests $17,459.10 in attorneys' fees and $653.91 in attorneys' costs, for a total request of $18,113.01. In accordance with General Order #9, petitioner did not incur any personal costs.
On July 13, 2018, respondent filed a response objecting to an award of attorneys' fees and costs because petitioner failed to establish a reasonable basis for her claim. Resp. at 3. Respondent argued that "the reasonable basis analysis must focus on whether there is evidentiary support for the claim set forth in the petition, not whether counsel acted reasonably in filing the petition."
On July 20, 2018, petitioner replied to respondent's opposition to her motion for attorneys' fees and costs. Petitioner stated, before filing the petition, her counsel relied on several extensive interviews with petitioner and her husband via telephone to obtain "petitioner's perspective on the development of her neurological condition, including the time of symptom onset." Reply at 2. Because petitioner's counsel found both petitioner and her husband credible, he "used the information they provided to inform his interpretation of the medical record."
This matter is now ripe for adjudication.
Under the Vaccine Act, a special master or a judge on the U.S. Court of Federal Claims may award fees and costs for an unsuccessful petition if "the petition was brought in good faith and there was a reasonable basis for the claim for which the petition was brought." 42 U.S.C. § 300aa-15(e)(1);
"Good faith" is a subjective standard.
"Reasonable basis" is not defined in the Vaccine Act or Rules. Deciding whether a claim was brought in good faith and had a reasonable basis "is within the discretion of the Special Master."
Petitioner is entitled to a presumption of good faith, and respondent does not contest that the petition was filed in good faith.
Petitioner filed her petition after March 20, 2017 when the U.S. Department of Health and Human Services added Table injuries to the Vaccine Injury Table, including GBS following flu vaccine. 42 C.F.R. § 100.3(a). In order to qualify for the Table injury GBS, a petitioner must actually have GBS and the onset must occur within 3-42 days of vaccination. Petitioner had the onset of her difficulty walking occurring in July 2015, three months before flu vaccination. The medical records show that the alleged onset of petitioner's GBS was February 16, 2016, over five months after petitioner's September 23, 2015 flu vaccination. Thus, petitioner would not satisfy the Table requirement of onset of 3-42 days. Petitioner had no reasonable expectation that she would prevail on a causation-in-fact basis either because the undersigned does not consider causation more than two months past flu vaccination compensable.
The undersigned finds that an award of attorneys' fees and costs to petitioner is unreasonable. Therefore, the undersigned
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith.